Advancements in RAS-targeted therapies are opening new pathways for treating previously undruggable cancer targets, with domestic firms increasing their research efforts.
Impact
10/100
Current rank score
9.65
Source tier
Tier 2
Category
Research
Firefly links to the original publisher. The summary above is AI-generated for orientation and may differ from the source. The “current rank score” decays over time so newer significant stories surface first.